Chapter 2 Pathology of Motor Neuron Disorders

Blue Books of Practical Neurology

Volumn 28, Issue C, 2003, Pages 17-49

  Wharton, Stephen ^a   Ince, Paul G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957157543     PISSN: 18773419     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1877-3419(09)70103-5     Document Type: Article

References (196)

1. Chou S.M. Pathology of Motor System Disorder. In: Leigh P.N., and Swash M. (Eds). Motor Neuron Disease: Biology and Management (1995), Springer-Verlag, London 53-92
2. Schmalbruch H., and Haase G. Spinal muscular atrophy: present state. Brain Pathol 11 (2001) 231-247
3. Osawa M., and Shishikura K. Werdnig-Hoffmann Disease and Variants. In: de Jong J.M.B.V., Vinken P., Bruyn R.P.M., et al. (Eds). Handbook of Clinical Neurology (1991), Elsevier, Amsterdam 51-80
4. Biros I., and Forrest S. Spinal muscular atrophy: untangling the knot?. J Med Genet 36 (1999) 1-8
5. Lefebvre S., Burgle Reboullet S., Clermont O., et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80 (1995) 1-5
6. Bingham P.M., Shen N., Rennert H., et al. Arthrogryposis is due to infantile neuronal degeneration associated with deletion of the SMNT gene. Neurology 49 (1997) 848-851
7. Vajsav J., Balslev T., Ray P.N., et al. Congenital cytoplasmic body myopathy with survival motor neuron gene deletion or Werdnig-Hoffmann disease. Neurology 51 (1998) 873-875
8. Lefebvre S., Burlet P., Liu Q., et al. Correlation between severity and SMN protein level in spinal muscular atrophy. Nature Genet 16 (1997) 265-269
9. Tizzano E., Cabot C., and Baiget M. Cell-specific survival motor neuron gene expression during human development of the central nervous system. Implications for the pathogenesis of spinal muscular atrophy. Am J Pathol 153 (1998) 355-361
10. Terns M.P., and Terns R.M. Macromolecular complexes: SMN-the master assembler. Current Biol 11 (2001) R862-R864
11. Jablonka S., Rossoll W., Schrank B., et al. The role of SMN in spinal muscular atrophy. J Neurol 247 (2000) I37-I42
12. Sendtner M. Molecular mechanisms in spinal muscular atrophy: models and perspectives. Current Opin Neurol 14 (2001) 629-634
13. Young P.J., Le T.T., Dunckley M., et al. Nuclear gems and Cajal (coiled) bodies in fetal tissues: nucleolar distribution of the spinal muscular atrophy protein, SMN. Exp Cell Res 265 (2001) 252-261
14. Iwahashi H., Eguchi Y., Yasuhara N., et al. Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy. Nature 390 (1997) 413-417
15. Lippa C.F., and Smith T.W. Chromatolytic neurons in Werdnig-Hoffman disease contain phosphorylated neurofilaments. Acta Neuropathol 77 (1988) 91-94
16. Fidzianska A., Goebel H.H., and Warlo I. Acute infantile spinal muscular atrophy. Brain 113 (1990) 433-445
17. Murayama S., Bouldin T.W., and Suzuki K. Immunocytochemical and ultrastructural studies of Werdnig-Hoffman disease. Acta Neuropathol 81 (1991) 408-417
18. Hayashi M., Arai N., Murakami T., et al. A study of cell death in Werdnig-Hoffmann disease brain. Neurosci Lett 243 (1998) 117-120
19. Lowe J., and Leigh P. Disorders of Movement and Systems Degeneration. In: Graham D., and Lantos P. (Eds). Greenfield's Neuropathology. 7th ed (2002), Arnold, London 325-420
20. Simic G., Seso-Simic D., Lucassen P.J., et al. Ultrastructural analysis and TUNEL demonstrate motor neuron apoptosis in Werdnig-Hoffmann disease. J Neuropathol Exp Neurol 59 (2000) 398-407
21. Kato S., and Hirano A. Ubiquitin and phosphorylated neurofilament epitopes in ballooned neurons of the extraocular muscle nuclei in a case of Werdnig-Hoffmann disease. Acta Neuropathol 80 (1990) 334-337
22. Iwata M., and Hirano A. Sparing of the Onufrowicz nucleus in sacral anterior horn lesions. Ann Neurol 4 (1978) 245-249
23. Sung J.H., and Mastri A.R. Spinal autonomic neurons in Werdnig-Hoffmann disease, mannosidosis, and Hurler's syndrome: distribution of autonomic neurons in the sacral spinal cord. J Neuropathol Exp Neurol 39 (1980) 441-451
24. Zierz S., and Zerres K. Wohlfart-Kugelberg-Welander Disease. In: de Jong J.M.B.V., Vinken P., Bruyn R.P.M., et al. (Eds). Handbook of Clinical Neurology (1991), Elsevier, Amsterdam 81-96
25. Chou S.M., and Wang H.S. Aberrant glycosylation/phosphorylation in chromatolytic motoneurons of Werdnig-Hoffmann disease. J Neurol Sci 152 (1997) 198-209
26. Ikemoto A., Hirano A., Matsumoto S., et al. Synaptophysin expression in the anterior horn of Werdnig-Hoffmann disease. J Neurol Sci 136 (1996) 94-100
27. Sobue G., Hashizume Y., and Yasuda T. Phosphorylated high molecular weight neurofilament protein in lower motor neurons in ALS and other neurodegenerative diseases involving the ventral horns. Acta Neuropathol 79 (1990) 402-408
28. Soler-Botija C., Ferrer I., Gich I., et al. Neuronal death is enhanced and begins during fetal development in type I spinal muscular atrophy spinal cord. Brain 125 (2002) 1624-1634
29. Grasl-Kraupp B., Ruttkay-Nedecky B., Koudelka H., et al. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis and autolytic cell death: a cautionary note. Hepatology 21 (1995) 1465-1468
30. Anderson J. Spinal Muscular Atrophy. In: Gresham G. (Ed). Current Histopathology: Atlas of Skeletal Muscle Pathology (1985), MTP Press, Lancaster 45-52
31. Walsh F., Moore S., and Lake B. Cell adhesion molecule N-CAM is expressed by denervated myofibers in Werdnig-Hoffmann and Kugelberg-Welander type spinal muscular atrophies. J Neurol Neurosurg Psychiatry 50 (1987) 439-442
32. Saito Y. Muscle fibre type differentiation and satellite cell population in Werdnig-Hoffmann disease. J Neurol Sci 68 (1985) 75-87
33. Swachak J., Benoff B., Sher J., et al. Werdnig-Hoffmann disease: myosin isoform expression is not arrested at prenatal stage of development. J Neurol Sci 95 (1990) 183-192
34. Soussi-Yanicostas N., Hamida B.C., Bejaoui K., et al. Evolution of muscle specific proteins in Werdnig-Hoffmann's disease. J Neurol Sci 109 (1992) 111-120
35. Tews D.S., and Goebel H.H. Apoptosis-related proteins in skeletal muscle fibers of spinal muscular atrophy. J Neuropathol Exp Neurol 56 (1997) 150-156
36. Williams B.Y., Vinnakota S., Sawyer C.A., et al. Differential subcellular localization of the survival motor neuron protein in spinal cord and skeletal muscle. Biochem Biophys Res Commun 254 (1999) 10-14
37. Guettier-Sigrist S., Hugel B., Coupin G., et al. Possible pathogenetic role of muscle cell dysfunction in motor neuron death in spinal muscular atrophy. Muscle Nerve 25 (2002) 700-708
38. Braun S., Croizal B., M-C L., et al. Constitutive muscular abnormalities in culture in spinal muscular atrophy. Lancet 345 (1995) 694-695
39. Amato A. Kennedy disease: a clinicopathologic correlation with mutations in the androgen receptor gene. Neurology 43 (1993) 791-794
40. Sobue G., Hashizume Y., Mukai E., et al. X-linked recessive bulbospinal neuronopathy-a clinico-pathological study. Brain 112 (1989) 209-232
41. La Spada A., Wilson E., Lubahn D., et al. Androgen receptor gene mutations in x-linked spinal and bulbar muscular atrophy. Nature (1991) 77-79
42. Dogu M., Sobue G., Mukai E., et al. Severity of X-linked recessive bulbospinal neuronopathy correlates with size of the tandem CAG repeat in the androgen receptor gene. Ann Neurol 32 (1992) 707-710
43. Guidetti D. X-linked bulbar and spinal muscular atrophy, or Kennedy disease: clinical, neuro-physiological, neuropathological, neuropsychological and molecular study of a large family. J Neurol Sci 135 (1996) 140-148
44. Li M., Nakagomi Y., Kobayashi Y., et al. Non-neural nuclear inclusions of androgen receptor protein in spinal and bulbar muscular atrophy. Am J Pathol 153 (1998) 695-701
45. MacLean H., Warne G., and Zajac J. Spinal and bulbar muscular atrophy: androgen receptor dysfunction caused by trinucleotide repeat expansion. J Neurol Sci 135 (1996) 149-157
46. Clancy A., Bonsall R., and Micheal R. Immunohistochemical labeling of androgen receptors in brain of monkey and rat. Life Sci 50 (1992) 409-417
47. Li M., Sobue G., Doyu M., et al. Primary sensory neurons in X-linked recessive bulbospinal neuronopathy: histopathology and androgen receptor gene expression. Muscle Nerve (1995) 301-308
48. Nakamura M., Mita S., Matuura T., et al. The reduction of androgen receptor mRNA in motoneurons of X-linked spinal and bulbar muscular atrophy. J Neurol Sci 150 (1997) 161-165
49. Brooks B.P., and Fischbeck K.H. Spinal and bulbar muscular atrophy: a trinucleotide-repeat expansion neurodegenerative disease. Trends Neurosci 18 (1995) 459-461
50. Gallo J. Kennedy's disease: a triplet repeat disorder or a motor neuron disease. Brain Res Bull 56 (2001) 209-214
51. Li M., Miwa S., Kobayashi Y., et al. Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy. Ann Neurol 44 (1998) 249-254
52. Yamada M. Pathology of CAG repeat diseases. Neuropathology 20 (2000) 319-325
53. Kennedy R., Alter M., and Sung J.H. Progressive proximal spinal and bulbar muscular atrophy of late onset: a sex linked recessive trait. Neurology 18 (1968) 671-680
54. Arbizu T., Santamaria J., Gomez J.M., et al. A family with adult spinal and bulbar muscular atrophy, X-linked inheritance and associated testicular failure. J Neurol Sci 59 (1983) 371-382
55. Nagashima T., Seko K., Hirose K., et al. Familial bulbo-spinal muscular atrophy associated with testicular atrophy and sensory neuropathy (Kennedy-Alter-Sung syndrome). Autopsy case report of two brothers. J Neurol Sci 87 (1988) 141-152
56. Terao S., Sobue G., Hashizume Y., et al. Disease-specific patterns of neuronal loss in the spinal ventral horn in amyotrophic lateral sclerosis, multiple system atrophy and X-linked bulbospinal neuronopathy, with special reference to the loss of small neurons in the intermediate zone. J Neurol 241 (1994) 196-203
57. Sobue G., Hashizume Y., Yasuda T., et al. Phosphorylated high molecular weight neurofilament protein in lower neurons in amyotrophic lateral sclerosis and other neurodegenerative diseases involving ventral horn cells. Acta Neuropathol 79 (1990) 402-408
58. Shaw P.J., Thagesen H., Tomkins J., et al. Kennedy's disease: new molecular pathological and clinical features. Neurology 51 (1998) 252-255
59. Wilde J., Moss T., and Thrush D. X-linked bulbospinal neuronopathy: a family study of 3 patients. J Neurol Neurosurg Psychiatry 50 (1987) 279-284
60. Harding A.E., et al. X-linked recessive bulbospinal neuropathy: a report of ten cases. J Neurol Neurosurg Psychiatry 45 (1982) 1012-1019
61. Sobue G., Doyu M., Kachi T., et al. Subclinical phenotypic expressions in heterozygous females of X-linked recessive bulbospinal neuropathy. J Neurol Sci 117 (1993) 74-78
62. Mulder D.W. The Postpolio Syndrome. In: de Jong J.M.B.V., Vinken P., Bruyn R.P.M., et al. (Eds). Handbook of Clinical Neurology (1991), Elsevier, Amsterdam 35-40
63. Kidd D., Williams A.J., and Howard R.S. Poliomyelitis. Postgrad Med J 72 (1996) 641-647
64. Halstead L. Post-polio syndrome. Sci Am 278 (1998) 42-47
65. Dalakas M. Pathogenetic mechanisms of post-polio syndrome: morphological, electrophysiological, virological and immunological correlations. Ann N Y Acad Sci 753 (1995) 167-185
66. Ohka S., and Nomoto A. Recent insights into poliovirus pathogenesis. Trends Micro 9 (2001) 501-506
67. Love S., and Wiley C. Viral Diseases. In: Graham D., and Lantos P. (Eds). Greenfield's Neuropathology (7th ed) (2002), Arnold, London 1-105
68. Bodian D. Histopathologic basis of diseased findings in poliomyelitis. Am J Med 6 (1949) 563-578
69. Kaminski H.J., Tresser N., Hogan R.E., et al. Spinal cord histopathology in long-term survivors of poliomyelitis. Muscle Nerve 18 (1995) 1208-1209
70. Pezeshkpour G.H., and Dalakas M.C. Long-term changes in the spinal cords of patients with old poliomyelitis-signs of continuous disease activity. Arch Neurol 45 (1988) 505-508
71. Fishman P.S. Late-convalescent poliomyelitis. Arch Neurol 44 (1987) 98-100
72. Ito H., and Hirano A. Comparative study of spinal cord ubiquitin expression in post-poliomyelitis and sporadic amyotrophic lateral sclerosis. Acta Neuropathol 87 (1994) 425-429
73. Dalakas M.C., Elder G., Hallett M., et al. A long-term follow-up study of patients with post-poliomyelitis neuromuscular symptoms. N Engl J Med 314 (1986) 959-961
74. Dalakas M.C. Morphologic changes in the muscles of patients with post-poliomyelitis neuromuscular symptoms. Neurology 38 (1988) 99-104
75. Semino-Mora C., and Dalakas M.C. Rimmed vacuoles with β-amyloid and ubiquitinated filamentous deposits in the muscles of patients with long-standing denervation (post-poliomyelitis muscular atrophy): similarities with inclusion body myositis. Hum Pathol 29 (1998) 1128-1133
76. Ince P.G., Lowe J., and Shaw P.J. Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. Neuropathol Appl Neurobiol 24 (1998) 104-117
77. Brownell B., Oppenheimer D.R., and Hughes J.T. The central nervous system in motor neurone disease. J Neurol Neurosurg Psychiatry 33 (1970) 338-357
78. Martin J.E., and Swash M. The Pathology of Motor Neuron Disease. In: Leigh P.N., and Swash M. (Eds). Motor Neuron Disease: Biology and Management (1995), Springer-Verlag, London 93-118
79. Bunina T.L. Intracellular inclusions in familial amyotrophic lateral sclerosis. Zh Neuropathol Pskyat 62 (1962) 1293-1299
80. Leigh P.N., Anderton B.H., Dodson A., et al. Ubiquitin deposits in anterior horn cells in motor neuron disease. Neurosci Lett 93 (1988) 197-203
81. Lowe J., Lennox G., Jefferson D., et al. A filamentous inclusion body within anterior horn neurons in motor neuron disease defined by immunocytochemical localization of ubiquitin. Neurosci Lett 93 (1988) 203-210
82. Chou S.M. Pathognomy of Intraneuronal Inclusions in ALS. In: Tsubaki T., and Toyokura Y. (Eds). Amyotrophic Lateral Sclerosis (1979), Tokyo University Press and University Park Press, Tokyo, Baltimore 135-177
83. Ince P.G., Tomkins J., Slade J.Y., et al. Amyotrophic lateral sclerosis associated with genetic abnormalities in the gene encoding superoxide dismutase: molecular pathology of five new cases and comparison with 73 sporadic cases and previous reports. J Neuropathol Exp Neurol 57 (1998) 895-904
84. Rouleau G.A., Clark A.W., Rooke K., et al. SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis. Ann Neurol 39 (1996) 128-131
85. Y-S P., Wakabayashi K., Kakita A., et al. Neuropathology with clinical correlations of sporadic amyotrophic lateral sclerosis: 102 autopsy cases examined between 1962 and 2000. Brain Pathol 12 (2003) 10-22
86. Sasaki K., and Iwata M. Ultrastructural study of Betz cells in the primary motor cortex of the human brain. J Anat 199 (2001) 699-708
87. Kusaka H. Neuropathology of the motor neuron disease-Bunina body. Clin Neurol 39 (1999) 65-66
88. Okamoto K., Hirai S., Amari M., et al. Bunina bodies in amyotrophic lateral sclerosis immuno-stained with rabbit antiserum. Neurosci Lett 162 (1993) 125-128
89. Sasaki S., and Maruyama S. Ultrastructural study of Bunina bodies in the anterior horn neurons of patients with amyotrophic lateral sclerosis. Neurosci Lett 154 (1993) 117-120
90. Tomonaga M., Saito M., Yoshimura M., et al. Ultrastructure of the Bunina bodies in anterior horn cells of amyotrophic lateral sclerosis. Acta Neuropathol 42 (1978) 81-86
91. Leigh P.N., Dodson A., Swash M., et al. Cytoskeletal abnormalities in motor neuron disease: an immunocytochemical study. Brain 112 (1989) 521-535
92. Leigh P.N., Whitwell H., Garofalo O., et al. Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis: morphology, distribution and specificity. Brain 114 (1991) 775-788
93. Love S., Saitoh T., Quijada S., et al. Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies. J Neuropathol Exp Neurol 47 (1988) 393-405
94. Lowe J., Blanchard A., Morrell K., et al. Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease and Alzheimer's disease as well as Rosenthal fibers in cerebellar astrocytomas, cytoplasmic inclusion bodies in muscle and Mallory bodies in alcoholic liver disease. J Pathol 155 (1988) 9-15
95. Lowe J. New pathological findings in amyotrophic lateral sclerosis. J Neurol Sci 124 suppl (1994) 38-51
96. Mather K., Martin J.E., Swash M., et al. Histochemical and immunocytochemical study of ubiquitinated neuronal inclusions in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 19 (1993) 141-145
97. Sasaki S., Toi S., Shirata A., et al. Immunohistochemical and ultrastructural study of basophilic inclusions in adult-onset motor neuron disease. Acta Neuropathol 102 (2001) 200-206
98. Ince P.G. Neuropathology. In: Brown R.J., Meininger V., and Swash M. (Eds). Amyotrophic Lateral Sclerosis (2000), Martin Dunitz, London 83-112
99. Ince P., Evans J., Forster G., et al. Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology 60 (2003) 1252-1258
100. Hirano A., Kurland L.T., and Sayre G.P. Familial amyotrophic lateral sclerosis: a subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusions. Arch Neurol 16 (1967) 232-243
101. Schochet J.S., Hardmann J.M., Ladewig P.P., and Earle K.M. Intraneuronal conglomerates in sporadic motor neuron disease. Arch Neurol 20 (1969) 548-553
102. Kondo A., Iwaki T., Tateishi J., et al. Accumulation of neurofilaments in a sporadic case of amyotrophic lateral sclerosis. Jpn J Psychiatry Neurol 40 (1986) 677-684
103. Hirano A., Donnefeld H., Sasaki S., and Nakano I. Fine structural observations on neurofilamentous changes in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 43 (1984) 461-470
104. Katayama S., Watanabe C., Kohriyama T., et al. Gallyas-positive argyrophilic and ubiquitinated filamentous inclusions in rapidly progressive motor neuron disease: Immunohistochemical and electron microscopic studies. Acta Neuropathol 100 (2000) 221-227
105. Carpenter S. Proximal axonal enlargement in motor neuron disease. Neurology 18 (1968) 841-851
106. Wong N., He B., and Strong M. Characterization of neuronal intermediate filament protein expression in cervical spinal neurons in sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 59 (2000) 972-982
107. Mannetto V., Sternberger N.H., Perry G., et al. Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 47 (1988) 642-653
108. Munoz D.G., Greene C., Perl D.P., and Selkoe D.J. Accumulation of phosphorylated neurofilaments in anterior horn motoneurons of amyotrophic lateral sclerosis patients. J Neuropathol Exp Neurol 47 (1988) 9-18
109. Arima K., Ogawa M., Sunohara N., et al. Immunohistochemical and ultrastructural characterization of ubiquitinated eosinophilic fibrillary neuronal inclusions in sporadic amyotrophic lateral sclerosis. Acta Neuropathol 96 (1998) 75-85
110. Takahashi K., Nakamura H., and Okada E. Hereditary amyotrophic lateral sclerosis. Arch Neurol 27 (1972) 292-299
111. Tanaka S., Yase Y., and Yoshimasu H. Familial amyotrophic lateral sclerosis. Ultrastructural study of intraneuronal hyaline inclusion material. Adv Neurol Sci 24 (1980) 386-387
112. Metcalf C., and Hirano A. Clinicopathological studies of a family with amyotrophic lateral sclerosis. Arch Neurol 24 (1971) 518-523
113. Sasaki S., Yamane K., Sakuma H., and Murayama S. Sporadic motor neuron disease with Lewy body-like hyaline inclusions. Acta Neuropathol 78 (1989) 555-560
114. Murayama S., Mori H., Ihara Y., et al. Immunocytochemical and ultrastructural studies of lower motor neurons in ALS. Ann Neurol 27 (1990) 137-148
115. Murayama S., Ookawa Y., Mori H., et al. Immunocytochemical and ultrastructural study of Lewy body-like inclusions in familial amyotrophic lateral sclerosis. Acta Neuropathol 78 (1989) 143-152
116. Konagaya M., Sakai M., Matsuoka Y., et al. Upper motor neuron predominant degeneration with frontal and temporal lobe atrophy. Acta Neuropathol 96 (1998) 532-536
117. Watanabe R., Iino M., Honda M., et al. Primary lateral sclerosis. Neuropathology 17 (1997) 220-224
118. Hudson A.J. Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review. Brain 104 (1981) 217-247
119. Wilkstrom J., Paetau A., Palo J., et al. Classic amyotrophic lateral sclerosis with dementia. Arch Neurol 39 (1982) 681-683
120. Mitsuyama Y. Presenile dementia with motor neuron disease in Japan: clinicopathological review of 26 cases. J Neurol Neurosurg Psychiatry 47 (1984) 953-959
121. Mitsuyama Y. Presenile dementia with motor neuron disease. Dement Geriatr Cogn Disord 4 (1993) 137-142
122. Mitsuyama Y., Kogoh H., and Ata K. Progressive dementia with motor neuron disease: an additional case report and neuropathological review of 20 cases in Japan. Eur Arch Psychiatry Neurol Sci 235 (1985) 1-8
123. Neary D., Snowden J.S., Mann D., et al. Frontal lobe dementia and motor neurone disease. J Neurol Neurosurg Psychiatry 53 (1990) 23-32
124. Morita K., Kaiya H., Ikeda T., and Namba M. Presenile dementia combined with amyotrophy: a review of 34 Japanese cases. Arch Gerontol Geriatr 6 (1987) 263-277
125. Gallassi R., Montaga P., Ciardulli C., et al. Cognitive impairment in motor neuron disease. Acta Neurol Scand 71 (1985) 480-484
126. Peavy G.M., Herzog A.G., Rubin N.P., and Mesulam M.M. Neuropsychological aspects of dementia of motor neuron disease: a report of two cases. Neurology 42 (1992) 1004-1008
127. Caselli R.J., Windebank A.J., Petersen R.C., and Komori T. Rapidly progressive aphasic dementia and motor neuron disease. Ann Neurol 33 (1993) 200-207
128. Wightman G., Anderson V., Martin J., et al. Hippocampal and neocortical ubiquitin-immunore-active inclusions in amyotrophic lateral sclerosis with dementia. Neurosci Lett 139 (1992) 269-277
129. Okamoto K., Hirai S., Yamazaki Y., et al. New ubiquitin-positive intraneuronal inclusions in the extra-motor cortices in patients with amyotrophic lateral sclerosis. Neurosci Lett 129 (1991) 233-236
130. Brun A., Englund B., Gustafson L., et al. Consensus on clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 57 (1994) 416-418
131. Kawashima T., Kikuchi H., Takita M., et al. Skein-like inclusions in the neostriatum from a case of amyotrophic lateral sclerosis with dementia. Acta Neuropathol 96 (1998) 541-545
132. Kawashima T., Furuta A., Doh-ura K., et al. Ubiquitin-immunoreactive skein-like inclusions in the neostriatum are not restricted to amyotrophic lateral sclerosis, but are rather aging-related structures. Acta Neuropathol 100 (2000) 43-49
133. Cooper P., Jackson M., Lennox G., et al. Tau, ubiquitin, and αB crystallin immunohistochemistry define the principal causes of degenerative frontotemporal dementia. Arch Neurol 52 (1995) 1011-1015
134. Holton L., Révész T., Crooks R., and Scaravilli F. Evidence for pathological involvement of the spinal cord in motor neuron disease-inclusion dementia. Acta Neuropathol 103 (2002) 221-227
135. Tsuchiya K., Ozawa E., Fukushima J., et al. Rapidly progressive aphasia and motor neuron disease: a clinical, radiological and pathological study of an autopsy case with circumscribed lobar atrophy. Acta Neuropathol 99 (2000) 81-87
136. Castaigne P., Lhermitte F., Cambier J., et al. Étude neuropathologique de 61 observations de sclérose latérale amyotrophique: discussion nosologique. Rev Neurol 127 (1972) 401-414
137. Iwata M., and Hirano A. Current Problems in the Pathology of Amyotrophic Lateral Sclerosis. In: Zimmerman H.M. (Ed). Progress in Neuropathology (1979), Raven Press, New York 277-298
138. Lawyer T.J., and Netsky M.G. Amyotrophic lateral sclerosis: a clinicopathological study of 53 cases. Arch Neurol Psychiatry 69 (1953) 171-192
139. Dyck P.J., Stevens J.C., Mulder D.W., and Espinosa R.E. Frequency of nerve fiber degeneration of peripheral and sensory neurons in amyotrophic lateral sclerosis. Neurology 25 (1975) 781-785
140. Bradley W.G., Good P., Rasool C.G., and Adelman L.S. Morphometric and biochemical studies of peripheral nerves in amyotrophic lateral sclerosis. Ann Neurol 14 (1983) 267-277
141. Averback P., and Crocker P. Regular involvement of Clarke's nucleus in sporadic amyotrophic lateral sclerosis. Arch Neurol 39 (1982) 155-156
142. Swash M., Leader M., Brown A., and Swettenham K.W. Focal loss of anterior horn cells in the cervical cord in motor neuron disease. Brain 109 (1986) 939-952
143. Takasu T., Mizutani T., Sakamaki S., et al. An autopsy case of sporadic amyotrophic lateral sclerosis with degeneration of the spinocerebellar tracts and the posterior columns. Ann Rep Neurodeg Dis Res Committee in Japan (1985) 94-100
144. Shimizu T., Kawata A., Kato S., et al. Autonomic failure in ALS with a novel SOD1 mutation. Neurology 54 (2000) 1534-1537
145. Tabuchi T., Takahashi K., and Tanaka F. Familial ALS with ophthalmoplegia. Clin Neurol 23 (1983) 278-287
146. Mizutani T., Sakamaki S., Tsuchiya N., et al. Amyotrophic lateral sclerosis with ophthalmoplegia and multisystem degeneration in patients on long term use of respirators. Acta Neuropathol 84 (1992) 372-377
147. Hayashi H., and Kato S. Total manifestations of amyotrophic lateral sclerosis (ALS) in the totally locked-in state. J Neurol Sci 93 (1989) 19-35
148. Akiyama K., Tsutusumi H., Onoda N., et al. An autopsy case of sporadic amyotrophic lateral sclerosis with sensory disturbances and ophthalmoplegia. Rinsho Byori 5 (1987) 921-927
149. Sudo S., Fukutani Y., Matsubara R., et al. Motor neuron disease with dementia combined with degeneration of striatonigral and pallidoluysian systems. Acta Neuropathol 103 (2002) 521-525
150. Machida Y., Tsuchiya K., Anno M., et al. Sporadic amyotrophic lateral sclerosis with multiple system degeneration: a report of an autopsy case without respirator administration. Acta Neuropathol 98 (1999) 512-515
151. Su M., Yoshida Y., Ishiguro H., and Hirota K. Nigral degeneration in a case of amyotrophic lateral sclerosis. Evidence of Lewy body-like and skein inclusions in the pigmented neurons. Clin Neuropathol 18 (1999) 293-300
152. Al-Sarraj S., Maekawa S., Kibble M., et al. Ubiquitin only intraneuronal inclusion in the substantia nigra is a characteristic feature of motor neurone disease with dementia. Neuropathol Appl Neurobiol 28 (2002) 120-128
153. Ince P.G., Shaw P.J., Slade J.Y., et al. Familial amyotrophic lateral sclerosis with a mutation in exon 4 of the Cu/Zn superoxide dismutase gene: pathological and immunocytochemical changes. Acta Neuropathol 92 (1996) 395-403
154. Chou S.M., Wang H.S., and Taniguchi A. Role of SOD1 and nitric oxide/cyclic GMP cascade on neurofilament aggregation in ALS/MND. J Neurol Sci 139 suppl (1996) 16-26
155. Kokubo Y., Kuzahara S., Narita Y., et al. Accumulation of neurofilaments and SOD1-immunoreactive products in a patient with familial amyotrophic lateral sclerosis with I113T SOD1 mutation. Arch Neurol 56 (1999) 1506-1508
156. Shaw C.E., Enayat Z.E., Powell J.F., et al. Familial amyotrophic lateral sclerosis: molecular pathology of a patient with a SOD1 mutation. Neurology 49 (1997) 1612-1616
157. Sasaki S., Yamane K., Sakuma H., and Iwata M. An unusual case of familial amyotrophic lateral sclerosis with extensive involvement and neuronal cytoplasmic inclusions. Neuropathol Appl Neurobiol 26 (2000) 398-402
158. Takahashi H., Makifuchi T., Nakano R., et al. Familial amyotrophic lateral sclerosis with a mutation in the Cu/Zn superoxide dismutase gene. Acta Neuropathol 88 (1994) 185-188
159. Takehisa Y., Ujike H., Ishizu H., et al. Familial amyotrophic lateral sclerosis with a novel Leu126Ser mutation in the copper/zinc superoxide dismutase gene showing mild clinical features and Lewy body-like hyaline inclusions. Arch Neurol 58 (2001) 736-740
160. Cervenakova L., Protas I., Hirano A., et al. Progressive muscular atrophy variant of familial amyotrophic lateral sclerosis (PMA/ALS). J Neurol Sci 177 (2000) 124-130
161. Kedekawa J., Fujimura H., Ogawa Y., et al. A clinicopathological study of a patient with familial amyotrophic lateral sclerosis associated with a two base pair deletion in the copper/zinc superoxide dismutase (SOD1) gene. Acta Neuropathol 94 (1997) 617-622
162. Kato S., Shimoda M., Watanabe Y., et al. Familial amyotrophic lateral sclerosis with a two base pair deletion in superoxide dismutase 1 gene: multisystem degeneration with intracytoplasmic hyaline inclusions in astrocytes. J Neuropathol Exp Neurol 55 (1996) 1089-1101
163. Ohi T., Saita K., Takechi S., et al. Clinical features and neuropathological findings of familial amyotrophic lateral sclerosis with a His46Arg mutation in Cu/Zn superoxide dismutase. J Neurol Sci 197 (2002) 73-78
164. Cudkowicz M.E., McKenna-Yasek D., Chen C., et al. Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene. Ann Neurol 43 (1998) 703-710
165. Shibata N., Hirano A., Kobayashi M., et al. Cu/Zn superoxide dismutase-like immunoreactivity in Lewy body-like inclusions of sporadic amyotrophic lateral sclerosis. Neurosci Lett 179 (1994) 149-152
166. Shibata N., Hirano A., Kobayashi M., et al. Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J Neuropathol Exp Neurol 55 (1996) 481-490
167. Bruijn L., Becher M., Lee M., et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18 (1997) 327-338
168. Bruijn L.M.K.H., Kato S., et al. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281 (1998) 1851-1854
169. Sasaki S., Ohsawa Y., Yamane K., et al. Familial amyotrophic lateral sclerosis with widespread vacuolation and hyaline inclusions. Neurology 51 (1998) 871-873
170. Watanabe M., Dykes-Hoberg M., Cullota V., et al. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Neurobiol Dis 8 (2001) 933-941
171. Shibata N., Hirano A., Kobayashi M., et al. Presence of Cu/Zn superoxide dismutase (SOD) immunoreactivity in neuronal hyaline inclusions in spinal cords from mice carrying a transgene for Gly93Ala mutant human Cu/Zn SOD. Acta Neuropathol 95 (1998) 136-142
172. Matsumoto S., Kusaka H., Ito H., et al. Sporadic amyotrophic lateral sclerosis with dementia and Cu/Zn superoxide dismutase-positive Lewy body-like inclusions. Clin Neuropathol 15 (1996) 41-46
173. Kato S., Horiuchi S., Nakashima K., et al. Astrocytic hyaline inclusions contain advanced glycation end products in familial amyotrophic lateral sclerosis with superoxide dismutase 1 gene mutation: immunohistochemical and immunoelectron microscopical analyses. Acta Neuropathol 97 (1999) 260-266
174. Kato S., Nakashima K., Horiuchi S., et al. Formation of advanced glycation end-product-modified superoxide dismutase-1 (SOD1) is one of the mechanisms responsible for inclusions common to familial amyotrophic lateral sclerosis patients with SOD1 gene mutation, and transgenic mice expressing human SOD1 gene mutation. Neuropathology 21 (2001) 67-81
175. Shibata N. Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Neuropathology 21 (2001) 82-92
176. Bruyn R.P.M., and Scheltens P. Hereditary Spastic Paraparesis (Strümpell-Lorrain). In: de Jong J.M.B.V., Vinken P., Bruyn R.P.M., and Klawans H. (Eds). Handbook of Clinical Neurology (1991), Elsevier, Amsterdam 301-318
177. McDermott C.J., White K., Bushby K., and Shaw P.J. Hereditary spastic paraparesis: a review of new developments. J Neurol Neurosurg Psychiatry 69 (2000) 150-160
178. Harding A.E. Hereditary "pure" spastic paraplegia: a clinical and genetic study of 22 families. J Neurol Neurosurg Psychiatry 44 (1981) 871-883
179. Fink J.K., Heiman-Patterson T., Bird T.D., et al. Hereditary spastic paraplegia: advances in genetic research. Hereditary Spastic Paraplegia Working Group. Neurology 46 (1996) 1507-1515
180. Figlewicz D., and Bird T.D. "Pure" hereditary spastic paraplegias. Neurology 53 (1999) 5-7
181. Sack Jr. G.H., Huether C.A., and Garg N. Familial spastic paraplegia-clinical and pathologic studies in a large kindred. Johns Hopkins Med J 143 (1978) 117-121
182. Strümpell A. Ueber eine bestimmte Form der primaren combinierten Systemerkrankung des Ruckenmarks. Arch Psychiatry Nervenkr 17 (1886) 217-238
183. Schwartz G. Hereditary (familial) spastic paraplegia. Arch Neurol Psychiatry 68 (1952) 655-682
184. Behan W., and Maia M. Strümpell's familial spastic paraplegia: genetics and neuropathology. J Neurol Neurosurg Psychiatry 37 (1974) 8-20
185. Schwartz G., and Liu C. Hereditary (familial) spastic paraplegia: further clinical and pathologic observations. Arch Neurol Psychiatry 75 (1956) 144-162
186. Casari G., and Rugarli E. Molecular basis of inherited spastic paraplegias. Curr Opin Genet Dev 11 (2001) 336-342
187. Errico A., Ballabio A., and Rugarli E.I. Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics. Hum Mol Genet 11 (2002) 153-163
188. Tedeshi G., Alloca S., DiConstanzo A., et al. Multisystem involvement of the central nervous system in Strümpell's disease. J Neurol 103 (1991) 55-60
189. Byrne P.C., McMonagle P., Webb S., et al. Age-related cognitive decline in hereditary spastic paraparesis linked to chromosome 2p. Neurology 1 (2000) 1510-1517
190. McMonagle P., Byrne P.C., Fitzgerald B., et al. Phenotype of AD-HSP due to mutations in the SPAST gene: comparison with AD-HSP without mutations. Neurology 55 (2000) 1794-1800
191. Webb S., Coleman D., Byrne P.C., et al. Autosomal dominant hereditary spastic paraparesis with cognitive loss linked to chromosome 2p. Brain 121 (1998) 601-609
192. Ferrer I., Olive M., Rivera R., et al. Hereditary spastic paraparesis with dementia, amyotrophy and peripheral neuropathy. A neuropathological study. Neuropathol Appl Neurobiol 21 (1995) 255-261
193. White K.D., Ince P.G., Lusher M.E., et al. Clinical and pathologic findings in hereditary spastic paraparesis with spastin mutation. Neurology 55 (2000) 89-94
194. Casari G., De Fusco M., Ciarmatori S., et al. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 93 (1998) 973-983
195. McDermott C.J., Dayaratne R.K., Tomkins J., et al. Paraplegin gene analysis in hereditary spastic paraparesis (HSP) pedigrees in north east England. Neurology 56 (2001) 467-471
196. Hedera P., DiMauro S., Bonilla E., et al. Phenotypic analysis of autosomal dominant hereditary spastic paraplegia linked to chromosome 8q. Neurology 1 (1999) 44-49